glp-1 washington When is a drug too potent? Washington - Patients lose “spectacular”

"What people can do is build environments a food environment, a movement environment, a light environment where their biology works the way it evolved to work

Increased FBP levels destabilize the RCC2Rac1 complex, likely by direct binding of FBP to RCC2, leading to Rac1 activation, cell spreading and adhesion

While these medications offer glycemic control and cardiovascular benefits, the risks have increased because of their potential impact on cancer risk, particularly colorectal cancer (CRC)

A Phase 2 clinical trial published in the New England Journal of Medicine in 2023 reported mean body weight reductions of approximately 24% at 48 weeks at the highest studied dose